Search

Author/Creator Liu, Longding

12. The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18–59 years: A phase I randomized, double-blinded, controlled trial. Issue 20 (12th May 2021)

Authors:
Pu, Jing; Yu, Qin; Yin, Zhifang; Zhang, Ying; Li, Xueqi; Yin, Qiongzhou; Chen, Hongbo; Long, Runxiang; Zhao, Zhimei; Mou, Tangwei; Zhao, Heng; Feng, Shiyin; Xie, Zhongping; Wang, Lichun; He, Zhanlong; Liao, Yun; Fan, Shengtao; Jiang, Ruiju; Wang, Jianfeng; Zhang, Lingli
Journal:
Vaccine
Issue:
Volume 39:Issue 20(2021)
Page Start:
2746
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models. Issue 1 (1st January 2021)

Authors:
Li, Dandan; Luan, Ning; Li, Jing; Zhao, Heng; Zhang, Ying; Long, Runxiang; Jiang, Guorun; Fan, Shengtao; Xu, Xingli; Cao, Han; Wang, Yunfei; Liao, Yun; Wang, Lichun; Liu, Longding; Liu, Cunbao; Li, Qihan
Journal:
Emerging microbes & infections
Issue:
Volume 10:Issue 1(2021)
Page Start:
2194
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗